2021
DOI: 10.1016/j.bjid.2021.101601
|View full text |Cite
|
Sign up to set email alerts
|

Time-dependent decay of detectable antibodies against SARS-CoV-2: A comparison of ELISA with two batches of a lateral-flow test

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
3
2
1

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(2 citation statements)
references
References 28 publications
0
2
0
Order By: Relevance
“…For example, in a population-based COVID-19 epidemiological study (EPICOVID-RS) carried out in 9 different cities in Rio Grande do Sul state (Brazil), the high accuracy of the S-UFRJ test (used from the 9 th study round on) allowed the determination of a logit-linear relationship between the exposure level of study participants and the seroprevalence [6] . In the 8 first rounds of the study, a commercial rapid antibody test had been used, but it was replaced by the S-UFRJ test after a comparative evaluation indicated a clear superiority of the S-UFRJ ELISA [33] .…”
Section: Discussionmentioning
confidence: 99%
“…For example, in a population-based COVID-19 epidemiological study (EPICOVID-RS) carried out in 9 different cities in Rio Grande do Sul state (Brazil), the high accuracy of the S-UFRJ test (used from the 9 th study round on) allowed the determination of a logit-linear relationship between the exposure level of study participants and the seroprevalence [6] . In the 8 first rounds of the study, a commercial rapid antibody test had been used, but it was replaced by the S-UFRJ test after a comparative evaluation indicated a clear superiority of the S-UFRJ ELISA [33] .…”
Section: Discussionmentioning
confidence: 99%
“…However, tests to evaluate the specific cellular immune response for SARS-CoV-2 are not yet commercially available. Antibodies against S protein, where the receptor-binding domain (RBD) is located, are particular for SARS-CoV-2 [26]; their levels correlated with the virus's neutralization capacity [27].…”
Section: 1 Specimen Collectionmentioning
confidence: 99%